No Data
No Data
Convertible Stock List (Part 2) [Parabolic Signal Convertible Stock List]
○ List of sales conversion stocks market code stock name closing price SAR Tokyo Stock Exchange Prime <1899> Fukuda Gumi 5540 5850 <1926> Light Engineering 2060 2144 <1982> Hibiya Setsu 3080 3175 <2153 > EJ HD 1827 1885 <2222> Kotobuki Spirits 1
Alfresa, Suzuken, etc. (added) Rating
Target Stock Price Change Code | Stock Name | Securities Company | Conventional | After Change |------|-----------------|-----------|--------|--------|<2784>|Alfresa | Nomura | 2550 yen | 2260 yen |<9987>|Suzuken | Nomura | 5000 yen | 5370 yen |<8050>|Seiko G | Nomura
Sony G, 24/3 operating profit down 7.2% to 1,208.8 billion yen, 25/3 forecast 5.5% increase to 1.275 trillion yen
The financial results for the fiscal year ending 2024/3 announced by Sony G <6758> were sales revenue of 13.20.768 billion yen, up 18.6% from the previous fiscal year, and operating profit of 1,208.8 billion yen, down 7.2% from the same period. As for the financial results for the fiscal year ending 2025/3, we plan that sales revenue will decrease 5.5% from the previous fiscal year to 12.31 trillion yen, and operating profit will increase 5.5% to 1.275 billion yen. It was announced that 1 share will be split into 5 shares using 9/30 as the reference date. Also, it is 2.46% of the number of issued shares (excluding treasury stock)
VMS BioMarketing Names "Nurse of The Year"
Impact Patient Engagement Award Shines the Spotlight on Two Outstanding VMS Clinical Nurse EducatorsINDIANAPOLIS, May 14, 2024 /PRNewswire/ -- During this year's National Nurses Week, VMS BioMarketin
Medley 1Q Net Y466.00M Vs Net Y358.00M
Medley Inc. (4480.TO) Japan 1st Quarter Ended March 31 GROUP 2024 2023 Revenue Y5.95 bln Y4.44 bln Operating Profit Y246.00 mln Y380
MEDLEY: Presentation of financial results for the 1st quarter of the fiscal year ending 2024/12
No Data